ClinicalTrials.Veeva

Menu

Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Aortic Valve, Bicuspid

Treatments

Other: Study the natural history of bicuspid

Study type

Observational

Funder types

Other

Identifiers

NCT03139786
PI2012_843_0014

Details and patient eligibility

About

The aortic valve bicuspidia (BVA) is a congenital condition corresponding to the presence of 2 sigmoids instead of 3. This is the most common cardiac congenital anomaly affecting 0.5 to 2% of the population The general rule. BVA may be associated with structural damage to the ascending aorta, which exposes BVA patients to a risk of developing ascending aortic aneurysm and acute aortic accidents. Recent data from the literature have revealed that the natural history of BVA is marked by a possible development towards significant valvulopathy and / or an ascending aortic aneurysm often requiring surgical treatment. However, the natural history of bicuspid disease remains poorly understood and the prognostic factors for progression to severe valvulopathy and / or aneurysmal dilatation of the ascending aorta remain to be determined.

Enrollment

232 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients examined in the echocardiography laboratory whose objective examination was a bicuspid valve of the aortic valve
  • Bicuspidia may be formerly known

Exclusion criteria

  • Refusal to participate
  • Patients who had already undergone bicuspid surgery or ascending aorta before being examined at the echocardiography laboratory

Trial contacts and locations

1

Loading...

Central trial contact

Christophe TRIBOUILLOY, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems